Jung YH - Search Results

1

Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.

Nam G, Jung JM, Park HJ, Baek SY, Baek KS, Mok HY, Kim DE, Jung YH. Nam G, et al. Among authors: jung yh, jung jm. Bioorg Med Chem. 2019 Aug 1;27(15):3408-3420. doi: 10.1016/j.bmc.2019.06.036. Epub 2019 Jun 20. Bioorg Med Chem. 2019. PMID: 31235266

2

Syntheses of (+/-)-homoepibatidine analogues.

Kim YH, Oh CY, Lee KY, Lee YS, Jung YH, Park HJ, Ham WH. Kim YH, et al. Among authors: jung yh. Arch Pharm Res. 2002 Feb;25(1):49-52. doi: 10.1007/BF02975260. Arch Pharm Res. 2002. PMID: 11885691

3

Identification of novel ligands for the RNA pseudoknot that regulate -1 ribosomal frameshifting.

Park SJ, Jung YH, Kim YG, Park HJ. Park SJ, et al. Among authors: jung yh. Bioorg Med Chem. 2008 Apr 15;16(8):4676-84. doi: 10.1016/j.bmc.2008.02.025. Epub 2008 Feb 13. Bioorg Med Chem. 2008. PMID: 18321712 Free PMC article.

4

Synthesis of norlignans and in vitro inhibitory activity of antigen-induced degranulation.

Park E, Yang YJ, Kim A, Kwak JH, Jung YH, Kang SC, Kim IS. Park E, et al. Among authors: jung yh. Bioorg Med Chem Lett. 2012 Jun 1;22(11):3653-5. doi: 10.1016/j.bmcl.2012.04.033. Epub 2012 Apr 13. Bioorg Med Chem Lett. 2012. PMID: 22543029

5

[(4-Hydroxyl-benzo[4,5]thieno[3,2-c]pyridine-3-carbonyl)-amino]-acetic acid derivatives; HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues.

Hong YR, Kim HT, Lee SC, Ro S, Cho JM, Kim IS, Jung YH. Hong YR, et al. Among authors: jung yh. Bioorg Med Chem Lett. 2013 Nov 1;23(21):5953-7. doi: 10.1016/j.bmcl.2013.08.067. Epub 2013 Aug 23. Bioorg Med Chem Lett. 2013. PMID: 24042008

6

Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation.

Hong YR, Kim HT, Ro S, Cho JM, Lee SH, Kim IS, Jung YH. Hong YR, et al. Among authors: jung yh. Bioorg Med Chem Lett. 2014 Jul 15;24(14):3142-5. doi: 10.1016/j.bmcl.2014.05.003. Epub 2014 May 15. Bioorg Med Chem Lett. 2014. PMID: 24894560

7

Discovery of (E)-5-(benzylideneamino)-1H-benzo[d]imidazol-2(3H)-one derivatives as inhibitors for PTK6.

Shim HJ, Yang HR, Kim HI, Kang SA, No KT, Jung YH, Lee ST. Shim HJ, et al. Among authors: jung yh. Bioorg Med Chem Lett. 2014 Oct 1;24(19):4659-4663. doi: 10.1016/j.bmcl.2014.08.036. Epub 2014 Aug 23. Bioorg Med Chem Lett. 2014. PMID: 25205190

8

Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling.

Kim SJ, Baek KS, Park HJ, Jung YH, Lee SM. Kim SJ, et al. Among authors: jung yh. Br J Pharmacol. 2016 Mar;173(6):1045-57. doi: 10.1111/bph.13414. Epub 2016 Feb 22. Br J Pharmacol. 2016. PMID: 26689981 Free PMC article.

9

Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.

Park JS, Im W, Choi S, Park SJ, Jung JM, Baek KS, Son HP, Sharma S, Kim IS, Jung YH. Park JS, et al. Among authors: jung yh, jung jm. Eur J Med Chem. 2016 Feb 15;109:75-88. doi: 10.1016/j.ejmech.2015.12.006. Epub 2015 Dec 10. Eur J Med Chem. 2016. PMID: 26761776

10

Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity.

Yoo J, Kim SJ, Son D, Seo H, Baek SY, Maeng CY, Lee C, Kim IS, Jung YH, Lee SM, Park HJ. Yoo J, et al. Among authors: jung yh. Eur J Med Chem. 2016 Jun 30;116:126-135. doi: 10.1016/j.ejmech.2016.03.046. Epub 2016 Mar 19. Eur J Med Chem. 2016. PMID: 27060764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters